Cargando…
From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
SIMPLE SUMMARY: Breast cancer is a disease that affects thousands of women around the world. Adequate treatment depends on the characterization of breast cancer subtypes. Tumors that are positive for the estrogen receptor represent the most common subtypes and have the best prognosis. However, many...
Autores principales: | Barazetti, Jéssica Fernanda, Jucoski, Tayana Shultz, Carvalho, Tamyres Mingorance, Veiga, Rafaela Nasser, Kohler, Ana Flávia, Baig, Jumanah, Al Bizri, Hend, Gradia, Daniela Fiori, Mader, Sylvie, Carvalho de Oliveira, Jaqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345104/ https://www.ncbi.nlm.nih.gov/pubmed/34359587 http://dx.doi.org/10.3390/cancers13153688 |
Ejemplares similares
-
MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
por: Carvalho, Tamyres Mingorance, et al.
Publicado: (2022) -
The Potential of NORAD–PUMILIO–RALGAPB Regulatory Axis as a Biomarker in Breast Cancer
por: Muller, Cristiane Sato Mara, et al.
Publicado: (2022) -
Long Non-Coding RNAs in Multifactorial Diseases: Another Layer of Complexity
por: Cipolla, Gabriel A., et al.
Publicado: (2018) -
So alike yet so different. Differential expression of the long non-coding RNAs NORAD and HCG11 in breast cancer subtypes
por: Mathias, Carolina, et al.
Publicado: (2021) -
LncRNA-SNPs in a Brazilian Breast Cancer Cohort: A Case-Control Study
por: Mathias, Carolina, et al.
Publicado: (2023)